Company Profile | ![]() | 0-9 | ![]() | A | ![]() | B | ![]() | C | ![]() | D | ![]() | E | ![]() | F | ![]() | G | ![]() | H | ![]() | I | ![]() | J | ![]() | K | ![]() | L | ![]() | M | ![]() | N | ![]() | O | ![]() | P | ![]() | Q | ![]() | R | ![]() | S | ![]() | T | ![]() | U | ![]() | V | ![]() | W | ![]() | X | ![]() | Y | ![]() | Z |
WPP plc
(NYSE: WPP)
|
8:00 PM UTC, 04/21/25 | |||
---|---|---|---|---|
Last: $35.18 | Change: -0.48 | %Change: -1.35% | Volume: 592,870 |
11:16 AM EST, 01/06/2025 (MT Newswires) -- European equities trading in the US as American depositary receipts were sharply higher late Monday morning, as the S&P Europe Select ADR Index rose 1.6% to 1,315.5.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and 3D printer company Materialise (MTLS), which climbed 20% and 6% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and semiconductor company Sequans Communications (SQNS) that increased almost 5% and 3%, respectively.
The worst decliners in continental Europe were pharmaceutical company Novo Nordisk (NVO) and consumer goods giant Unilever (UL) losing roughly 2% each. They were followed by pharmaceutical company Ascendis Pharma (ASND) and Natuzzi (NTZ), which were down nearly 2% and 1%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics, (AKTX) and alcoholic beverage company Diageo (DEO), gaining 6% and 3%, respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and insurance firm Prudential (PUK), which were up 2.6% and 2.9%, respectively.
The worst decliners in the UK and Ireland were biopharmaceutical company TC Biopharm (TCBP) and communications company WPP (WPP), shedding 11% and 2% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL), which dropped 2.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.